Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Roodman
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Anatomy
Physiology
Disorders
Living Beings
Chemicals & Drugs
Procedures
Sign-in to see full Profile
Network (preview)
43
Reddy, Sakamuri
20
Kurihara, Noriyoshi
14
Singer, Frederick
13
Windle, Jolene
13
Menaa, Cheikh
13
Mundy, Gregory
12
Leach, Robin
8
Choi, Sun Jin
8
Choi, SJ
8
Demulder, Anne
7
Dallas, Mark
6
Ehrlich, Lori
6
Chung, Ho Yeon
6
Lu, Ganwei
6
McManus, Linda
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Roodman (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Pal Rekha; Janz Martin; Galson Deborah L; Gries Margarete; Li Shirong; Jöhrens Korinna; Anagnostopoulos Ioannis; Dörken Bernd; Mapara Markus Y; Borghesi Lisa; Kardava Lela; Roodman G David; Milcarek Christine; Lentzsch Suzanne
C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.
Blood 2009;114(18):3890-8.
-
2009: Choi S J; Roodman G D; Feng J Q; Song I S; Amin K; Hart P S; Wright J T; Haruyama N; Hart T C
In vivo impact of a 4 bp deletion mutation in the DLX3 gene on bone development.
Developmental biology 2009;325(1):129-37.
-
2008: Hiruma Yuko; Kurihara Noriyoshi; Subler Mark A; Zhou Hua; Boykin Christina S; Zhang Heju; Ishizuka Seiichi; Dempster David W; Roodman G David; Windle Jolene J
A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Human molecular genetics 2008;17(23):3708-19.
-
2008: Roodman G David
Novel targets for myeloma bone disease.
Expert opinion on therapeutic targets 2008;12(11):1377-87.
-
2008: Coleman Robert E; Guise Theresa A; Lipton Allan; Roodman G David; Berenson James R; Body Jean-Jacques; Boyce Brendan F; Calvi Laura M; Hadji Peyman; McCloskey Eugene V; Saad Fred; Smith Matthew R; Suva Larry J; Taichman Russell S; Vessella Robert L; Weilbaecher Katherine N
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6387-95.
-
2008: Shiozawa Yusuke; Havens Aaron M; Jung Younghun; Ziegler Anne M; Pedersen Elisabeth A; Wang Jingcheng; Wang Jianhua; Lu Ganwei; Roodman G David; Loberg Robert D; Pienta Kenneth J; Taichman Russell S
Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.
Journal of cellular biochemistry 2008;105(2):370-80.
-
2008: Sharma Sanjai; Nemeth Elizabeta; Chen Yi-Hsiang; Goodnough Julia; Huston Alissa; Roodman G D; Ganz Tomas; Lichtenstein Alan
Involvement of hepcidin in the anemia of multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3262-7.
-
2008: Ishizuka Seiichi; Kurihara Noriyoshi; Hiruma Yuko; Miura Daishiro; Namekawa Jun-ichi; Tamura Azusa; Kato-Nakamura Yuko; Nakano Yusuke; Takenouchi Kazuya; Hashimoto Yuichi; Nagasawa Kazuo; Roodman G David
1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
The Journal of steroid biochemistry and molecular biology 2008;110(3-5):269-77.
-
2008: Roodman G David
Bone building with bortezomib.
The Journal of clinical investigation 2008;118(2):462-4.
-
2008: Roodman G David; Dougall William C
RANK ligand as a therapeutic target for bone metastases and multiple myeloma.
Cancer treatment reviews 2008;34(1):92-101.
-
2008: Roodman G David
Skeletal imaging and management of bone disease.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2008;():313-9.
-
2007: Esteve Flavia R; Roodman G David
Pathophysiology of myeloma bone disease.
Best practice & research. Clinical haematology 2007;20(4):613-24.
-
2007: Lentzsch Suzanne; Ehrlich Lori A; Roodman G David
Pathophysiology of multiple myeloma bone disease.
Hematology/oncology clinics of North America 2007;21(6):1035-49, viii.
-
2007: Roodman G D
Treatment strategies for bone disease.
Bone marrow transplantation 2007;40(12):1139-46.
-
2007: Cackowski Frank C; Roodman G David
Perspective on the osteoclast: an angiogenic cell?
Annals of the New York Academy of Sciences 2007;1117():12-25.
-
2007: Lentzsch Suzanne; Elliott Gary; Roodman G David
SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma.
Archiv der Pharmazie 2007;340(10):511-6.
-
2007: Lu Yi; Cai Zhong; Xiao Guozhi; Keller Evan T; Mizokami Atsushi; Yao Zhi; Roodman G David; Zhang Jian
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
Cancer research 2007;67(8):3646-53.
-
2007: Alsayed Yazan; Ngo Hai; Runnels Judith; Leleu Xavier; Singha Ujjal K; Pitsillides Costas M; Spencer Joel A; Kimlinger Teresa; Ghobrial Joanna M; Jia Xiaoying; Lu Ganwei; Timm Michael; Kumar Ashok; Côté Daniel; Veilleux Israel; Hedin Karen E; Roodman G David; Witzig Thomas E; Kung Andrew L; Hideshima Teru; Anderson Kenneth C; Lin Charles P; Ghobrial Irene M
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.
Blood 2007;109(7):2708-17.
-
2007: Feng Rentian; Anderson Gülsüm; Xiao Guozhi; Elliott Gary; Leoni Lorenzo; Mapara Markus Y; Roodman G David; Lentzsch Suzanne
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.
Blood 2007;109(5):2130-8.
-
2007: Garcia-Palacios Veronica; Chung Ho Yeon; Choi Sun Jin; Sarmasik Aliye; Kurihara Noriyoshi; Lee Jun Won; Galson Deborah L; Collins Robert; Roodman G David
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.
Bone 2007;40(2):316-22.
-
2007: Roodman G David
Bone-breaking cancer treatment.
Nature medicine 2007;13(1):25-6.
-
2007: Kurihara Noriyoshi; Hiruma Yuko; Zhou Hua; Subler Mark A; Dempster David W; Singer Frederick R; Reddy Sakamuri V; Gruber Helen E; Windle Jolene J; Roodman G David
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
The Journal of clinical investigation 2007;117(1):133-42.
-
2006: Kurihara Noriyoshi; Zhou Hua; Reddy Sakamuri V; Garcia Palacios Veronica; Subler Mark A; Dempster David W; Windle Jolene J; Roodman G David
Experimental models of Paget's disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21 Suppl 2():P55-7.
-
2006: Singer Frederick R; Mills Barbara G; Gruber Helen E; Windle Jolene J; Roodman G David
Ultrastructure of bone cells in Paget's disease of bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21 Suppl 2():P51-4.
-
2006: Huston Alissa; Brown Jason; Roodman G David
Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
Experimental hematology 2006;34(12):1616.
-
2006: Giuliani Nicola; Rizzoli Vittorio; Roodman G David
Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.
Blood 2006;108(13):3992-6.
-
2006: Francis Lanie K; Alsayed Yazan; Leleu Xavier; Jia Xiaoying; Singha Ujjal K; Anderson Judith; Timm Michael; Ngo Hai; Lu Ganwei; Huston Alissa; Ehrlich Lori A; Dimmock Elizabeth; Lentzsch Suzanne; Hideshima Teru; Roodman G David; Anderson Kenneth C; Ghobrial Irene M
Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6826-35.
-
2006: Reddy G Kesava; Mughal Tariq I; Roodman G David
Novel approaches in the management of myeloma-related skeletal complications.
Supportive cancer therapy 2006;4(1):15-8.
-
2006: Roodman G David
New potential targets for treating myeloma bone disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 2):6270s-6273s.
-
2006: Lipton Allan; Berenson James R; Body Jean-Jacques; Boyce Brendan F; Bruland Oyvind S; Carducci Michael A; Cleeland Charles S; Clohisy Denis R; Coleman Robert E; Cook Richard J; Guise Theresa A; Pearse Roger N; Powles Trevor J; Rogers Michael J; Roodman G David; Smith Matthew R; Suva Larry J; Vessella Robert L; Weilbaecher Katherine N; King Laura
Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(20 Pt 2):6209s-6212s.
-
2006: Rao Hongwei; Lu Ganwei; Kajiya Hiroshi; Garcia-Palacios Veronica; Kurihara Noriyoshi; Anderson Judy; Patrene Ken; Sheppard Dean; Blair Harry C; Windle Jolene J; Choi Sun Jin; Roodman G David
Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(10):1657-65.
-
2006: Aggarwal Rohit; Ghobrial Irene M; Roodman G David
Chemokines in multiple myeloma.
Experimental hematology 2006;34(10):1289-95.
-
2006: Lu Ganwei; Maeda Hidefumi; Reddy Sakamuri V; Kurihara Noriyoshi; Leach Robin; Anderson Judith L; Roodman G David
Cloning and characterization of the annexin II receptor on human marrow stromal cells.
The Journal of biological chemistry 2006;281(41):30542-50.
-
2006: Huston Alissa; Roodman G David
Role of the microenvironment in multiple myeloma bone disease.
Future oncology (London, England) 2006;2(3):371-8.
-
2006: Nguyen Aaron N; Stebbins Elizabeth G; Henson Margaret; O'Young Gilbert; Choi Sun J; Quon Diana; Damm Debby; Reddy Mamatha; Ma Jing Y; Haghnazari Edwin; Kapoun Ann M; Medicherla Satyanarayana; Protter Andy; Schreiner George F; Kurihara Noriyoshi; Anderson Judy; Roodman G David; Navas Tony A; Higgins Linda S
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
Experimental cell research 2006;312(10):1909-23.
-
2006: Garcia-Palacios Veronica; Chung Ho Yeon; Choi Sun Jin; Kurihara Noriyoshi; Lee Jun Won; Ehrlich Lori A; Collins Robert; Roodman G David
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression.
Annals of the New York Academy of Sciences 2006;1068():240-3.
-
2006: Roodman G David
Regulation of osteoclast differentiation.
Annals of the New York Academy of Sciences 2006;1068():100-9.
-
2006: Kurihara Noriyoshi; Zhou Hua; Reddy Sakamuri V; Garcia Palacios Veronica; Subler Mark A; Dempster David W; Windle Jolene J; Roodman G David
Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(3):446-55.
-
2005: Ehrlich Lori A; Roodman G David
The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma.
Immunological reviews 2005;208():252-66.
-
2005: Roodman G David
High bone turnover markers predict poor outcome in patients with bone metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4821-2.
-
2005: Ehrlich Lori A; Chung Ho Yeon; Ghobrial Irene; Choi Sun Jin; Morandi Francesca; Colla Simona; Rizzoli Vittorio; Roodman G David; Giuliani Nicola
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma.
Blood 2005;106(4):1407-14.
-
2005: Roodman G David;
Myeloma bone disease: pathogenesis and treatment.
Oncology (Williston Park, N.Y.) 2005;19(8):983-4, 986.
-
2005: Li Fanghong; Chung Hoyeon; Reddy Sakamuri V; Lu Ganwei; Kurihara Noriyoshi; Zhao Allan Z; Roodman G David
Annexin II stimulates RANKL expression through MAPK.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(7):1161-7.
-
2005: Ishizuka Seiichi; Kurihara Noriyoshi; Reddy Sakamuri V; Cornish Jillian; Cundy Tim; Roodman G David
(23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
Endocrinology 2005;146(4):2023-30.
-
2005: Murthy Raghavendra Vasudeva; Arbman Gunnar; Gao Jingfang; Roodman G David; Sun Xiao-Feng
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2293-9.
-
2005: Oba Yasuo; Lee Jun Won; Ehrlich Lori A; Chung Ho Yeon; Jelinek Diane F; Callander Natalie S; Horuk Richard; Choi Sun Jin; Roodman G David
MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Experimental hematology 2005;33(3):272-8.
-
2005: Roodman G David; Windle Jolene J
Paget disease of bone.
The Journal of clinical investigation 2005;115(2):200-8.
-
2004: Kurihara Noriyoshi; Reddy Sakamuri V; Araki Norie; Ishizuka Seiichi; Ozono Keiichi; Cornish Jillian; Cundy Tim; Singer Frederick R; Roodman G David
Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(7):1154-64.
-
2004: Ishizuka Seiichi; Kurihara Noriyoshi; Miura Daishiro; Takenouchi Kazuya; Cornish Jillian; Cundy Tim; Reddy Sakamuri V; Roodman G David
Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
The Journal of steroid biochemistry and molecular biology 2004;89-90(1-5):331-4.
-
2004: Kurihara Noriyoshi; Ishizuka Seiichi; Demulder Anne; Menaa Cheikh; Roodman G David
Paget's disease-a VDR coactivator disease?
The Journal of steroid biochemistry and molecular biology 2004;89-90(1-5):321-5.
-
2004: Roodman G David
Mechanisms of bone metastasis.
The New England journal of medicine 2004;350(16):1655-64.
-
2004: Roodman G David
Pathogenesis of myeloma bone disease.
Blood cells, molecules & diseases 2004;32(2):290-2.
-
2004: Roccisana Jennifer L; Kawanabe Noriaki; Kajiya Hiroshi; Koide Masanori; Roodman G David; Reddy Sakamuri V
Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells.
The Journal of biological chemistry 2004;279(11):10500-7.
-
2004: Lee Jun Won; Chung Ho Yeon; Ehrlich Lori A; Jelinek Diane F; Callander Natalie S; Roodman G David; Choi Sun Jin
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells.
Blood 2004;103(6):2308-15.
-
2004: Roodman G David; Choi Sun Jin
MIP-1 alpha and myeloma bone disease.
Cancer treatment and research 2004;118():83-100.
-
2003: Roodman G D
Mechanisms of bone resorption in myeloma.
Journal of musculoskeletal & neuronal interactions 2003;3(4):271-2; discussion 292-4.
-
2003: Oba Yasuo; Chung Ho Yeon; Choi Sun Jin; Roodman G David
Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(7):1332-41.
-
2003: Choi Sun J; Oba Tomoko; Callander Natalie S; Jelinek Diane F; Roodman G David
AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma.
Blood 2003;101(10):3778-83.
-
2002: Roodman G David
Role of the bone marrow microenvironment in multiple myeloma.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(11):1921-5.
-
2002: Darimont Christian; Avanti Ornella; Tromvoukis Yvonne; Vautravers-Leone Patricia; Kurihara Nori; Roodman G David; Colgin Lorel M; Tullberg-Reinert Heide; Pfeifer Andrea M A; Offord Elizabeth A; Mace Katherine
SV40 T antigen and telomerase are required to obtain immortalized human adult bone cells without loss of the differentiated phenotype.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2002;13(2):59-67.
-
2002: Friedrichs William E; Reddy Sakamuri V; Bruder Jan M; Cundy Tim; Cornish Jillian; Singer Frederick R; Roodman G David
Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(1):145-51.
-
2002: Anderson Kenneth C; Shaughnessy John D; Barlogie Bart; Harousseau Jean-Luc; Roodman G David
Multiple myeloma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():214-40.
-
2001: Choi S J; Oba Y; Gazitt Y; Alsina M; Cruz J; Anderson J; Roodman G D
Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease.
The Journal of clinical investigation 2001;108(12):1833-41.
-
2001: Choi S J; Kurihara N; Oba Y; Roodman G D
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(10):1804-11.
-
2001: Roodman G D
Studies in Paget's disease and their relevance to oncology.
Seminars in oncology 2001;28(4 Suppl 11):15-21.
-
2001: Roodman G D
Biology of osteoclast activation in cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3562-71.
-
2001: Callander N S; Roodman G D
Myeloma bone disease.
Seminars in hematology 2001;38(3):276-85.
-
2001: Dhodapkar M V; Jacobson J L; Gertz M A; Rivkin S E; Roodman G D; Tuscano J M; Shurafa M; Kyle R A; Crowley J J; Barlogie B
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).
Blood 2001;98(1):41-8.
-
2001: Reddy S V; Kurihara N; Menaa C; Landucci G; Forthal D; Koop B A; Windle J J; Roodman G D
Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
Endocrinology 2001;142(7):2898-905.
-
2001: Han J H; Choi S J; Kurihara N; Koide M; Oba Y; Roodman G D
Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand.
Blood 2001;97(11):3349-53.
-
2001: Choi S J; Han J H; Roodman G D
ADAM8: a novel osteoclast stimulating factor.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(5):814-22.
-
2001: Reddy S V; Kurihara N; Menaa C; Roodman G D
Paget's disease of bone: a disease of the osteoclast.
Reviews in endocrine & metabolic disorders 2001;2(2):195-201.
-
2001: Cruz J C; Alsina M; Craig F; Yoneda T; Anderson J L; Dallas M; Roodman G D
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
Experimental hematology 2001;29(4):441-7.
-
2001: Leach R J; Singer F R; Roodman G D
The genetics of Paget's disease of the bone.
The Journal of clinical endocrinology and metabolism 2001;86(1):24-8.
-
2000: Whyte M P; Mills B G; Reinus W R; Podgornik M N; Roodman G D; Gannon F H; Eddy M C; McAlister W H
Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(12):2330-44.
-
2000: Choi S J; Cruz J C; Craig F; Chung H; Devlin R D; Roodman G D; Alsina M
Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma.
Blood 2000;96(2):671-5.
-
2000: Menaa C; Reddy S V; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer F R; Bruder J M; Roodman G D
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
The Journal of clinical investigation 2000;105(12):1833-8.
-
2000: Rha S Y; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer M P; Roodman G D; Hurley L; Von Hoff D
Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):987-93.
-
2000: Kurihara N; Reddy S V; Menaa C; Anderson D; Roodman G D
Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.
The Journal of clinical investigation 2000;105(5):607-14.
-
2000: Menaa C; Barsony J; Reddy S V; Cornish J; Cundy T; Roodman G D
1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(2):228-36.
-
2000: Hentunen T A; Choi S J; Boyce B F; Dallas M R; Dallas S L; Shen-Ong G L; Roodman G D
A murine model of inflammatory bone disease.
Bone 2000;26(2):183-8.
-
2000: Menaa C; Kurihara N; Roodman G D
CFU-GM-derived cells form osteoclasts at a very high efficiency.
Biochemical and biophysical research communications 2000;267(3):943-6.
-
2000: Schaub R; Dupont B; Roodman G D; Leach R J; Reddy S V
Assignment of OSTF1 to human chromosome bands 12q24.1-->q24.2 by in situ hybridization.
Cytogenetics and cell genetics 2000;88(1-2):87-8.
-
1999: Reddy S V; Menaa C; Singer F R; Cundy T; Cornish J; Whyte M P; Roodman G D
Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone.
Experimental hematology 1999;27(10):1528-32.
-
1999: Leach R J; Singer F R; Cody J D; Roodman G D
Variable disease severity associated with a Paget's disease predisposition gene.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14 Suppl 2():17-20.
-
1999: Reddy S V; Menaa C; Singer F R; Demulder A; Roodman G D
Cell biology of Paget's disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14 Suppl 2():3-8.
-
1999: Choi S J; Reddy S V; Devlin R D; Menaa C; Chung H; Boyce B F; Roodman G D
Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption.
The Journal of biological chemistry 1999;274(39):27747-53.
-
1999: Halleen J M; Räisänen S; Salo J J; Reddy S V; Roodman G D; Hentunen T A; Lehenkari P P; Kaija H; Vihko P; Väänänen H K
Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase.
The Journal of biological chemistry 1999;274(33):22907-10.
-
1999: Roodman G D
Cell biology of the osteoclast.
Experimental hematology 1999;27(8):1229-41.
-
1999: Hentunen T A; Jackson S H; Chung H; Reddy S V; Lorenzo J; Choi S J; Roodman G D
Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen.
Endocrinology 1999;140(7):2954-61.
-
1999: Menaa C; Devlin R D; Reddy S V; Gazitt Y; Choi S J; Roodman G D
Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures.
The Journal of clinical investigation 1999;103(11):1605-13.
-
1999: Roodman G D
Mechanisms of abnormal bone turnover in Paget's disease.
Bone 1999;24(5 Suppl):39S-40S.
-
1998: Reddy S; Devlin R; Menaa C; Nishimura R; Choi S J; Dallas M; Yoneda T; Roodman G D
Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption.
Journal of cellular physiology 1998;177(4):636-45.
-
1998: Choi S J; Devlin R D; Menaa C; Chung H; Roodman G D; Reddy S V
Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.
The Journal of clinical investigation 1998;102(7):1360-8.
-
1998: Gao S J; Alsina M; Deng J H; Harrison C R; Montalvo E A; Leach C T; Roodman G D; Jenson H B
Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma.
The Journal of infectious diseases 1998;178(3):846-9.
-
1998: Nellissery M J; Padalecki S S; Brkanac Z; Singer F R; Roodman G D; Unni K K; Leach R J; Hansen M F
Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone.
American journal of human genetics 1998;63(3):817-24.
-
1998: Hentunen T A; Reddy S V; Boyce B F; Devlin R; Park H R; Chung H; Selander K S; Dallas M; Kurihara N; Galson D L; Goldring S R; Koop B A; Windle J J; Roodman G D
Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.
The Journal of clinical investigation 1998;102(1):88-97.
-
1998: Roodman G D; Ohsaki Y; Miller M M; Demulder A; Hosking D; Singer F R; McManus L M
Pagetic osteoclasts formed in vitro: absence of paracrystalline inclusions.
Journal of submicroscopic cytology and pathology 1998;30(2):315-27.
-
1998: Devlin R D; Reddy S V; Savino R; Ciliberto G; Roodman G D
IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1998;13(3):393-9.
-
1998: Roodman G D
Osteoclast differentiation and activity.
Biochemical Society transactions 1998;26(1):7-13.
-
1998: Roach J; Choi S J; Schaub R L; Leach R J; Roodman G D; Reddy S V
Further characterization of the murine collagenase (type IVB) gene promoter and analysis of mRNA expression in murine tissues.
Gene 1998;208(2):117-22.
-
1998: Reddy S V; Roodman G D
Control of osteoclast differentiation.
Critical reviews in eukaryotic gene expression 1998;8(1):1-17.
-
1998: Sachdev D; Ohsaki Y; Roodman G D; Chirgwin J M
Epitope mapping of recombinant human procathepsin D.
Advances in experimental medicine and biology 1998;436():185-9.
-
1997: Cody J D; Singer F R; Roodman G D; Otterund B; Lewis T B; Leppert M; Leach R J
Genetic linkage of Paget disease of the bone to chromosome 18q.
American journal of human genetics 1997;61(5):1117-22.
-
1997: Roodman G D
Mechanisms of bone lesions in multiple myeloma and lymphoma.
Cancer 1997;80(8 Suppl):1557-63.
-
1997: Uy H L; Mundy G R; Boyce B F; Story B M; Dunstan C R; Yin J J; Roodman G D; Guise T A
Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Cancer research 1997;57(15):3194-9.
-
1997: Tsai T W; Hammond L A; Rinaldi M; Martin K; Tio F; Maples J; Freytes C O; Roodman G D
Cokeromyces recurvatus infection in a bone marrow transplant recipient.
Bone marrow transplantation 1997;19(3):301-2.
-
1996: Reddy S V; Singer F R; Mallette L; Roodman G D
Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996;11(11):1602-7.
-
1996: Roodman G D
Paget's disease and osteoclast biology.
Bone 1996;19(3):209-12.
-
1996: Reddy S V; Alcantara O; Roodman G D; Boldt D H
Inhibition of tartrate-resistant acid phosphatase gene expression by hemin and protoporphyrin IX. Identification of a hemin-responsive inhibitor of transcription.
Blood 1996;88(6):2288-97.
-
1996: Roodman G D
Advances in bone biology: the osteoclast.
Endocrine reviews 1996;17(4):308-32.
-
1996: Whyte M P; Leelawattana R; Reddy S V; Roodman G D
Absence of paramyxo virus transcripts in juvenile Paget bone disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996;11(7):1041.
-
1996: Devlin R D; Bone H G; Roodman G D
Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease.
The Journal of clinical endocrinology and metabolism 1996;81(5):1893-7.
-
1996: Parfitt A M; Mundy G R; Roodman G D; Hughes D E; Boyce B F
A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1996;11(2):150-9.
-
1996: Alsina M; Boyce B; Devlin R D; Anderson J L; Craig F; Mundy G R; Roodman G D
Development of an in vivo model of human multiple myeloma bone disease.
Blood 1996;87(4):1495-501.
-
1996: Alsina M; Guise T A; Roodman G D
Cytokine regulation of bone cell differentiation.
Vitamins and hormones 1996;52():63-98.
-
1996: DuPont B R; Linn R; Knight C B; Roodman G D; Sakaguchi A Y; Lalley P A; Fournier R E; Leach R J
Assignment of matrix metalloproteinase 9 (Mmp9) to mouse chromosome 2 bands H1-H2.
Cytogenetics and cell genetics 1996;74(1-2):118-9.
-
1995: Boyce B F; Wright K; Reddy S V; Koop B A; Story B; Devlin R; Leach R J; Roodman G D; Windle J J
Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts.
Endocrinology 1995;136(12):5751-9.
-
1995: Hughes D E; Wright K R; Uy H L; Sasaki A; Yoneda T; Roodman G D; Mundy G R; Boyce B F
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(10):1478-87.
-
1995: Roodman G D
Osteoclast function in Paget's disease and multiple myeloma.
Bone 1995;17(2 Suppl):57S-61S.
-
1995: Alsina M; Boyce B F; Mundy G R; Roodman G D
An in vivo model of human multiple myeloma bone disease.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():48-50.
-
1995: Uy H L; Guise T A; De La Mata J; Taylor S D; Story B M; Dallas M R; Boyce B F; Mundy G R; Roodman G D
Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo.
Endocrinology 1995;136(8):3207-12.
-
1995: Bartkiewicz M; Hernando N; Reddy S V; Roodman G D; Baron R
Characterization of the osteoclast vacuolar H(+)-ATPase B-subunit.
Gene 1995;160(2):157-64.
-
1995: Reddy S V; Singer F R; Roodman G D
Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence.
The Journal of clinical endocrinology and metabolism 1995;80(7):2108-11.
-
1995: de la Mata J; Uy H L; Guise T A; Story B; Boyce B F; Mundy G R; Roodman G D
Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
The Journal of clinical investigation 1995;95(6):2846-52.
-
1995: Reddy S V; Kuzhandaivelu N; Acosta L G; Roodman G D
Characterization of the 5'-flanking region of the human tartrate-resistant acid phosphatase (TRAP) gene.
Bone 1995;16(5):587-93.
-
1995: Reddy S V; Hundley J E; Windle J J; Alcantara O; Linn R; Leach R J; Boldt D H; Roodman G D
Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(4):601-6.
-
1995: Takahashi S; Reddy S V; Dallas M; Devlin R; Chou J Y; Roodman G D
Development and characterization of a human marrow stromal cell line that enhances osteoclast-like cell formation.
Endocrinology 1995;136(4):1441-9.
-
1995: Uy H L; Dallas M; Calland J W; Boyce B F; Mundy G R; Roodman G D
Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(2):295-301.
-
1995: Takahashi S; Goldring S; Katz M; Hilsenbeck S; Williams R; Roodman G D
Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.
The Journal of clinical investigation 1995;95(1):167-71.
-
1995: Roodman G D
Application of bone marrow cultures to the study of osteoclast formation and osteoclast precursors in man.
Calcified tissue international 1995;56 Suppl 1():S22-3.
-
1994: Takahashi S; Reddy S V; Chirgwin J M; Devlin R; Haipek C; Anderson J; Roodman G D
Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption.
The Journal of biological chemistry 1994;269(46):28696-701.
-
1994: Adkins D R; Salzman D; Boldt D; Kuhn J; Irvin R; Roodman G D; Lyons R; Smith L; Freytes C O; LeMaistre C F
Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1890-901.
-
1994: Mills B G; Frausto A; Singer F R; Ohsaki Y; Demulder A; Roodman G D
Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens.
Bone 1994;15(4):443-8.
-
1994: Reddy S V; Takahashi S; Dallas M; Williams R E; Neckers L; Roodman G D
Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(5):753-7.
-
1994: Alcantara O; Reddy S V; Roodman G D; Boldt D H
Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron.
The Biochemical journal 1994;298 ( Pt 2)():421-5.
-
1994: Roodman G D
Biology of the osteoclast in Paget's disease.
Seminars in arthritis and rheumatism 1994;23(4):235-6.
-
1993: Hardin T C; Koeller J M; Kuhn J G; Roodman G D; Von Hoff D D
Nutritional parameters observed during 28-day infusion of recombinant human tumor necrosis factor-alpha.
JPEN. Journal of parenteral and enteral nutrition 1993;17(6):541-5.
-
1993: Demulder A; Takahashi S; Singer F R; Hosking D J; Roodman G D
Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease.
Endocrinology 1993;133(5):1978-82.
-
1993: Reddy S V; Scarcez T; Windle J J; Leach R J; Hundley J E; Chirgwin J M; Chou J Y; Roodman G D
Cloning and characterization of the 5'-flanking region of the mouse tartrate-resistant acid phosphatase gene.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993;8(10):1263-70.
-
1993: Reddy S V; Takahashi S; Haipek C; Chirgwin J M; Roodman G D
Tartrate-resistant acid phosphatase gene expression as a facile reporter gene for screening transfection efficiency in mammalian cell cultures.
BioTechniques 1993;15(3):444-7.
-
1993: Gallwitz W E; Mundy G R; Lee C H; Qiao M; Roodman G D; Raftery M; Gaskell S J; Bonewald L F
5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices.
The Journal of biological chemistry 1993;268(14):10087-94.
-
1993: Adkins D R; Irvin R; Kuhn J; Boldt D H; Roodman G D; Salzman D; Freytes C; Von Hoff D D; LeMaistre C F
A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.
Investigational new drugs 1993;11(2-3):169-79.
-
1993: Grimes R; Reddy S V; Leach R J; Scarcez T; Roodman G D; Sakaguchi A Y; Lalley P A; Windle J J
Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9.
Genomics 1993;15(2):421-2.
-
1993: Eckardt J R; Roodman G D; Boldt D H; Clark G M; Alvarez R; Page C; Gaskill H; LeMaistre C F
Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMT.
Bone marrow transplantation 1993;11(2):125-31.
-
1993: Marshall M V; Marshall M H; Degen D R; Roodman G D; Kuhn J G; Ross M E; Von Hoff D D
In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.
Stem cells (Dayton, Ohio) 1993;11(1):62-9.
-
1993: Roodman G D
Role of cytokines in the regulation of bone resorption.
Calcified tissue international 1993;53 Suppl 1():S94-8.
-
1992: Ohsaki Y; Takahashi S; Scarcez T; Demulder A; Nishihara T; Williams R; Roodman G D
Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone.
Endocrinology 1992;131(5):2229-34.
-
1992: Demulder A; Suggs S V; Zsebo K M; Scarcez T; Roodman G D
Effects of stem cell factor on osteoclast-like cell formation in long-term human marrow cultures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(11):1337-44.
-
1992: Roodman G D
Interleukin-6: an osteotropic factor?
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(5):475-8.
-
1992: Roodman G D; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith J F; Singer F R
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
The Journal of clinical investigation 1992;89(1):46-52.
-
1992: Mundy G R; Roodman G D; Bonewald L F; Yoneda T; Sabatini M
Effects of TNF and lymphotoxin on bone cells.
Immunology series 1992;56():483-98.
-
1991: Kurihara N; Civin C; Roodman G D
Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991;6(3):257-61.
-
1991: Roodman G D
Osteoclast differentiation.
Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists 1991;2(3):389-409.
-
1991: Mundy G R; Roodman G D; Bonewald L F; Oreffo R O; Boyce B F
Assays for bone resorption and bone formation.
Methods in enzymology 1991;198():502-10.
-
1991: Roodman G D; Kuehl T J; Vandeberg J L; Muirhead D Y
In utero bone marrow transplantation of fetal baboons with mismatched adult baboon marrow.
Blood cells 1991;17(2):367-75.
-
1991: Sunderland M C; Roodman G D
Interleukin-3. Its biology and potential uses in pediatric hematology/oncology.
The American journal of pediatric hematology/oncology 1991;13(4):414-25.
-
1990: Kurihara N; Gluck S; Roodman G D
Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long-term human marrow cultures.
Endocrinology 1990;127(6):3215-21.
-
1990: Muirhead D Y; Kuehl T J; Vandeberg J L; Menchaca E M; Downs M P; Roodman G D
Mixed lymphocyte culture reactivity of fetal baboons: application for in utero bone marrow transplantation.
Bone marrow transplantation 1990;6(4):263-7.
-
1990: Kurihara N; Roodman G D
Interferons-alpha and -gamma inhibit interleukin-1 beta-stimulated osteoclast-like cell formation in long-term human marrow cultures.
Journal of interferon research 1990;10(5):541-7.
-
1990: Chenu C; Kurihara N; Mundy G R; Roodman G D
Prostaglandin E2 inhibits formation of osteoclastlike cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor beta.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1990;5(7):677-81.
-
1990: Kurihara N; Bertolini D; Suda T; Akiyama Y; Roodman G D
IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(11):4226-30.
-
1990: Clibon U; Bonewald L; Caro J; Roodman G D
Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo.
Experimental hematology 1990;18(5):438-41.
-
1990: Kurihara N; Chenu C; Miller M; Civin C; Roodman G D
Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures.
Endocrinology 1990;126(5):2733-41.
-
1990: Kukita A; Bonewald L; Rosen D; Seyedin S; Mundy G R; Roodman G D
Osteoinductive factor inhibits formation of human osteoclast-like cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):3023-6.
-
1990: Kukita A; Chenu C; McManus L M; Mundy G R; Roodman G D
Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.
The Journal of clinical investigation 1990;85(4):1280-6.
-
1989: Li X F; Anderson J; Hutzler D; Roodman G D
Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha.
Experimental hematology 1989;17(11):1059-62.
-
1989: Johnson R A; Roodman G D
Hematologic manifestations of malignancy.
Disease-a-month : DM 1989;35(11):721-68.
-
1989: Kukita T; Roodman G D
Development of a monoclonal antibody to osteoclasts formed in vitro which recognizes mononuclear osteoclast precursors in the marrow.
Endocrinology 1989;125(2):630-7.
-
1989: Johnson R A; Waddelow T A; Caro J; Oliff A; Roodman G D
Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice.
Blood 1989;74(1):130-8.
-
1989: Williams D M; Bonewald L F; Roodman G D; Byrne G I; Magee D M; Schachter J
Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.
Infection and immunity 1989;57(5):1351-5.
-
1989: Kukita T; McManus L M; Miller M; Civin C; Roodman G D
Osteoclast-like cells formed in long-term human bone marrow cultures express a similar surface phenotype as authentic osteoclasts.
Laboratory investigation; a journal of technical methods and pathology 1989;60(4):532-8.
-
1989: Johnson R A; Boyce B F; Mundy G R; Roodman G D
Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
Endocrinology 1989;124(3):1424-7.
-
1989: Pfeilschifter J; Chenu C; Bird A; Mundy G R; Roodman G D
Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1989;4(1):113-8.
-
1989: Takahashi N; Kukita T; MacDonald B R; Bird A; Mundy G R; McManus L M; Miller M; Boyde A; Jones S J; Roodman G D
Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures.
The Journal of clinical investigation 1989;83(2):543-50.
-
1989: Roodman G D; Johnson R A; Clibon U
Tumor necrosis factor alpha and the anemia of chronic disease: effects of chronic exposure to TNF on erythropoiesis in vivo.
Advances in experimental medicine and biology 1989;271():185-96.
-
1988: Chenu C; Pfeilschifter J; Mundy G R; Roodman G D
Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(15):5683-7.
-
1988: Takahashi N; Yamana H; Yoshiki S; Roodman G D; Mundy G R; Jones S J; Boyde A; Suda T
Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.
Endocrinology 1988;122(4):1373-82.
-
1988: Roodman G D; Vandeberg J L; Kuehl T J
In utero bone marrow transplantation of fetal baboons with mismatched adult marrow: initial observations.
Bone marrow transplantation 1988;3(2):141-7.
-
1987: Roodman G D; Bird A; Hutzler D; Montgomery W
Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
Experimental hematology 1987;15(9):928-35.
-
1987: Gardner F H; Alperin J B; Belli J A; Farley P C; Frenkel E P; Redman J R; Roodman G D; Sears D A; Trowbridge A A
Hematology-oncology. Hematology-Oncology Workgroup, Legislative Task Force on Cancer in Texas.
Texas medicine 1987;83(9 Pt 2):59-71.
-
1987: Takahashi N; Mundy G R; Kuehl T J; Roodman G D
Osteoclast-like cell formation in fetal and newborn long-term baboon marrow cultures is more sensitive to 1,25-dihydroxyvitamin D3 than adult long-term marrow cultures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1987;2(4):311-7.
-
1987: Roodman G D; LeMaistre C F; Clark G M; Page C P; Newcomb T F; Knight W A
CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
Bone marrow transplantation 1987;2(2):165-73.
-
1987: MacDonald B R; Takahashi N; McManus L M; Holahan J; Mundy G R; Roodman G D
Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures.
Endocrinology 1987;120(6):2326-33.
-
1987: Lee J C; Kuehl T J; Roodman G D
Developmental changes in membrane proteins from baboon erythrocytes.
Comparative biochemistry and physiology. B, Comparative biochemistry 1987;88(1):223-6.
-
1987: Roodman G D
Mechanisms of erythroid suppression in the anemia of chronic disease.
Blood cells 1987;13(1-2):171-84.
-
1986: Takahashi N; Mundy G R; Roodman G D
Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(11):3544-9.
-
1986: Takahashi N; MacDonald B R; Hon J; Winkler M E; Derynck R; Mundy G R; Roodman G D
Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures.
The Journal of clinical investigation 1986;78(4):894-8.
-
1986: MacDonald B R; Mundy G R; Clark S; Wang E A; Kuehl T J; Stanley E R; Roodman G D
Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1986;1(2):227-33.
-
1985: Roodman G D; Ibbotson K J; MacDonald B R; Kuehl T J; Mundy G R
1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(23):8213-7.
-
1985: Roodman G D; VandeBerg J L; Kuehl T J
Expression of latent hematopoietic progenitor cells in cultures of newborn and adult baboon liver.
Blood 1985;65(6):1518-25.
-
1985: Roodman G D
Changes in the growth requirements of baboon liver hematopoietic progenitors during ontogeny.
Progress in clinical and biological research 1985;193():43-54.
-
1984: Ibbotson K J; Roodman G D; McManus L M; Mundy G R
Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells.
The Journal of cell biology 1984;99(2):471-80.
-
1983: Roodman G D; Horadam V W; Wright T L
Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease.
Blood 1983;62(2):406-12.
-
1983: Roodman G D; Lee J; Gidari A S
Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow.
British journal of haematology 1983;53(4):621-8.
-
1982: Roodman G D; Clare C N; Mills G
Congenital dyserythropoietic anaemia type II (CDA-II): chromosomal banding studies and adherent cell effects on erythroid colony (CFU-E) and burst (BFU-E) formation.
British journal of haematology 1982;50(3):499-507.
-
1981: Roodman G D; Spivak J L; Zanjani E D
Stimulation of erythroid colony formation in vitro by erythropoietin immobilized on agarose-bound lectins.
The Journal of laboratory and clinical medicine 1981;98(5):684-90.
-
1981: Roodman G D; Kaplan J M; Kaplan M E; Zanjani E D
Effects of shortened erythropoietin exposure on sheep marrow cultures.
British journal of haematology 1981;47(2):195-201.
-
1980: Roodman G D; Ascensao J L; Banisadre M; Bloom P M; Zanjani E D
Autoimmune pancytopenia. Lymphocyte inhibition of autologous but not allogenic bone marrow growth in vitro.
The American journal of medicine 1980;69(2):325-8.
-
1980: Roodman G D; Reese E P; Cardamone J M
Aplastic anemia associated with rubber cement used by a marathon runner.
Archives of internal medicine 1980;140(5):703.
-
1979: Roodman G D; Zanjani E D
Endogenous erythroid colony-forming cells in fetal and newborn sheep.
The Journal of laboratory and clinical medicine 1979;94(5):699-707.
-
1976: Roodman G D; Hutton J J; Bollum F J
DNA polymerase, thymidine kinase and DNA synthesis in erythropoietic mouse spleen cells separated on bovine serum albumin gradients.
Biochimica et biophysica acta 1976;425(4):478-91.
-
1975: Roodman G D; Hutton J J; Bollum F J
DNA polymerase activities during erythropoiesis. Effects of erythropietin, vinblastine, colcemid, and daunomycin.
Experimental cell research 1975;91(2):269-78.
Sign-in to see more